Search

Your search keyword '"Kälviäinen, Reetta"' showing total 730 results

Search Constraints

Start Over You searched for: Author "Kälviäinen, Reetta" Remove constraint Author: "Kälviäinen, Reetta"
730 results on '"Kälviäinen, Reetta"'

Search Results

2. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

3. A FinnGen pilot clinical recall study for Alzheimer’s disease

4. Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy

5. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

6. The ENIGMA‐Epilepsy working group: Mapping disease from large data sets

7. Structural network alterations in focal and generalized epilepsy assessed in a worldwide ENIGMA study follow axes of epilepsy risk gene expression

8. Shared genetic basis between genetic generalized epilepsy and background electroencephalographic oscillations

11. Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study

12. FinnGen provides genetic insights from a well-phenotyped isolated population

13. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

14. Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study

17. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

18. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

19. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET)

20. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

21. A worldwide ENIGMA study on epilepsy-related gray and white matter compromise across the adult lifespan

24. Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population

25. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland

26. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries.

27. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

28. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study

37. Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher‐level emergency: Consensus recommendations of an expert working group

38. Novel LAMC3pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy

39. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

40. Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.

43. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

44. Long-term Risk of Epilepsy in Subarachnoid Hemorrhage Survivors With Positive Family History: A Population-Based Follow-up Study

45. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

49. In depth behavioral phenotyping unravels complex motor disturbances in Cstb−/− mouse, a model for progressive myoclonus epilepsy type 1.

Catalog

Books, media, physical & digital resources